Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Cohance Lifesciences LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543064NSE Symbol: COHANCEP/E(TTM):99.04
ISIN Demat:INE03QK01018Div & Yield %:0EPS(TTM):9.23
Book Value(Rs):60.8611266Market Cap ( Cr.):34972.38Face Value(Rs):1
    Change Company 
(Rs In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
SOURCES OF FUNDS :      
Share Capital 25.4625.4625.4625.4625.4612.73
Reserves Total 2290.092002.891723.921495.241039.73770.10
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds2315.552028.351749.381520.701065.19782.83
Secured Loans 70.0038.5869.1695.5799.7826.26
Unsecured Loans 28.6426.431.181.5543.26159.94
Total Debt98.6465.0170.3497.12143.04186.20
Other Liabilities0.000.007.878.896.658.31
Total Liabilities2414.192093.361827.591626.711214.88977.34
APPLICATION OF FUNDS :      
Gross Block 996.62928.90713.00694.97568.76456.83
Less : Accumulated Depreciation 311.83259.28200.98160.77127.60100.09
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 684.79669.62512.02534.20441.16356.74
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress253.93179.08164.8129.9996.32101.71
Producing Properties0.000.000.000.000.000.00
Investments 1116.20892.57710.06599.90426.24276.32
Current Assets, Loans & Advances      
Inventories 154.12231.20311.47283.42201.08174.87
Sundry Debtors 242.47133.66109.66236.37102.38117.20
Cash and Bank22.6221.7346.2332.959.5613.96
Loans and Advances 97.9963.7494.9175.0071.0754.83
Total Current Assets517.20450.33562.27627.74384.10360.86
Less : Current Liabilities and Provisions      
Current Liabilities 122.5258.3484.93133.06110.4298.16
Provisions 16.3115.044.167.722.617.77
Total Current Liabilities138.8373.3889.10140.78113.03105.93
Net Current Assets378.37376.95473.17486.96271.07254.92
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets22.0311.591.401.472.471.94
Deferred Tax Liability56.8258.9243.0538.8733.4029.54
Net Deferred Tax-34.79-47.33-41.65-37.40-30.93-27.60
Other Assets15.6922.479.1613.0711.0115.26
Total Assets2414.192093.361827.581626.721214.87977.35
Contingent Liabilities18.7518.116.076.076.079.51